company background image
ELAB

Elliptic Laboratories OB:ELABS Stock Report

Last Price

kr20.40

Market Cap

kr2.1b

7D

7.6%

1Y

-27.0%

Updated

11 Aug, 2022

Data

Company Financials +
ELABS fundamental analysis
Snowflake Score
Valuation0/6
Future Growth5/6
Past Performance0/6
Financial Health5/6
Dividends0/6

ELABS Stock Overview

Elliptic Laboratories ASA, an artificial intelligence (AI) software company, provides AI virtual smart sensors for the smartphone, laptop, Internet of Things, and automotive industries.

Elliptic Laboratories Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Elliptic Laboratories
Historical stock prices
Current Share Pricekr20.40
52 Week Highkr29.50
52 Week Lowkr16.08
Beta0
1 Month Change13.59%
3 Month Change10.27%
1 Year Change-27.01%
3 Year Changen/a
5 Year Changen/a
Change since IPO32.90%

Recent News & Updates

Shareholder Returns

ELABSNO SoftwareNO Market
7D7.6%-5.9%1.9%
1Y-27.0%-39.0%9.8%

Return vs Industry: ELABS exceeded the Norwegian Software industry which returned -39.1% over the past year.

Return vs Market: ELABS underperformed the Norwegian Market which returned 8.7% over the past year.

Price Volatility

Is ELABS's price volatile compared to industry and market?
ELABS volatility
ELABS Average Weekly Movement5.7%
Software Industry Average Movement10.2%
Market Average Movement6.8%
10% most volatile stocks in NO Market12.5%
10% least volatile stocks in NO Market3.7%

Stable Share Price: ELABS is not significantly more volatile than the rest of Norwegian stocks over the past 3 months, typically moving +/- 6% a week.

Volatility Over Time: ELABS's weekly volatility (6%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
200670Laila Danielsenhttps://www.ellipticlabs.com

Elliptic Laboratories ASA, an artificial intelligence (AI) software company, provides AI virtual smart sensors for the smartphone, laptop, Internet of Things, and automotive industries. The company offers AI Virtual Presence Sensor, a presence-detection solution used to improve the security of data stored on laptops; AI Virtual Proximity Sensor that enables exquisite full-screen devices; 3D touchless gesture support service; AI Virtual Gesture Sensor, a touch-free ultrasound gesture technology; AI Virtual Presence Sensor, which delivers presence-sensing capabilities to various devices that possesses a speaker, microphone, and audio processor; and AI Virtual Connection Sensor that allows to pair and authenticate smart devices in the same room. It serves in Norway, China, Taiwan, South Korea, the United States, and Japan.

Elliptic Laboratories Fundamentals Summary

How do Elliptic Laboratories's earnings and revenue compare to its market cap?
ELABS fundamental statistics
Market Capkr2.12b
Earnings (TTM)-kr18.41m
Revenue (TTM)kr63.21m

33.6x

P/S Ratio

-115.3x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
ELABS income statement (TTM)
Revenuekr63.21m
Cost of Revenuekr61.92m
Gross Profitkr1.29m
Other Expenseskr19.71m
Earnings-kr18.41m

Last Reported Earnings

Jun 30, 2022

Next Earnings Date

Nov 17, 2022

Earnings per share (EPS)-0.18
Gross Margin2.04%
Net Profit Margin-29.13%
Debt/Equity Ratio3.6%

How did ELABS perform over the long term?

See historical performance and comparison
We’ve recently updated our valuation analysis.

Valuation

Is ELABS undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Below Fair Value

  • Significantly Below Fair Value

  • Analyst Forecast

Key Valuation Metric

Which metric is best to use when looking at relative valuation for ELABS?

Other financial metrics that can be useful for relative valuation.

ELABS key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue30.4x
Enterprise Value/EBITDA-75.9x
PEG Ration/a

Price to Sales Ratio vs Peers

How does ELABS's PS Ratio compare to its peers?

ELABS PS Ratio vs Peers
The above table shows the PS ratio for ELABS vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyPSEstimated GrowthMarket Cap
Peer Average4.8x
PEXIP Pexip Holding
1.7x14.4%kr1.5b
SIKRI Sikri Holding
2.5xn/akr1.5b
SMCRT SmartCraft
10.8x15.2%kr3.1b
MRCEL Mercell Holding
4.2x12.7%kr3.2b
ELABS Elliptic Laboratories
33.6x100.6%kr2.1b

Price-To-Sales vs Peers: ELABS is expensive based on its Price-To-Sales Ratio (33.6x) compared to the peer average (4.8x).


Price to Earnings Ratio vs Industry

How does ELABS's PE Ratio compare vs other companies in the NO Software Industry?

Price-To-Sales vs Industry: ELABS is expensive based on its Price-To-Sales Ratio (33.6x) compared to the Norwegian Software industry average (3x)


Price to Sales Ratio vs Fair Ratio

What is ELABS's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

ELABS PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio33.6x
Fair PS Ratio22.6x

Price-To-Sales vs Fair Ratio: ELABS is expensive based on its Price-To-Sales Ratio (33.6x) compared to the estimated Fair Price-To-Sales Ratio (22.6x).


Share Price vs Fair Value

What is the Fair Price of ELABS when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate ELABS's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate ELABS's fair value for valuation analysis.


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.


Discover undervalued companies

Future Growth

How is Elliptic Laboratories forecast to perform in the next 1 to 3 years based on estimates from 1 analyst?

Future Growth Score

5/6

Future Growth Score 5/6

  • Earnings vs Savings Rate

  • Earnings vs Market

  • High Growth Earnings

  • Revenue vs Market

  • High Growth Revenue

  • Future ROE


193.6%

Forecasted annual earnings growth

Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: ELABS is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (1.1%).

Earnings vs Market: ELABS is forecast to become profitable over the next 3 years, which is considered above average market growth.

High Growth Earnings: ELABS is expected to become profitable in the next 3 years.

Revenue vs Market: ELABS's revenue (100.6% per year) is forecast to grow faster than the Norwegian market (-0.9% per year).

High Growth Revenue: ELABS's revenue (100.6% per year) is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if ELABS's Return on Equity is forecast to be high in 3 years time


Discover growth companies

Past Performance

How has Elliptic Laboratories performed over the past 5 years?

Past Performance Score

0/6

Past Performance Score 0/6

  • Quality Earnings

  • Growing Profit Margin

  • Earnings Trend

  • Accelerating Growth

  • Earnings vs Industry

  • High ROE


27.1%

Historical annual earnings growth

Earnings and Revenue History

Quality Earnings: ELABS is currently unprofitable.

Growing Profit Margin: ELABS is currently unprofitable.


Past Earnings Growth Analysis

Earnings Trend: ELABS is unprofitable, but has reduced losses over the past 5 years at a rate of 27.1% per year.

Accelerating Growth: Unable to compare ELABS's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: ELABS is unprofitable, making it difficult to compare its past year earnings growth to the Software industry (13.5%).


Return on Equity

High ROE: ELABS has a negative Return on Equity (-5.55%), as it is currently unprofitable.


Discover strong past performing companies

Financial Health

How is Elliptic Laboratories's financial position?

Financial Health Score

5/6

Financial Health Score 5/6

  • Short Term Liabilities

  • Long Term Liabilities

  • Debt Level

  • Reducing Debt

  • Stable Cash Runway

  • Forecast Cash Runway

Financial Position Analysis

Short Term Liabilities: ELABS's short term assets (NOK241.4M) exceed its short term liabilities (NOK15.3M).

Long Term Liabilities: ELABS's short term assets (NOK241.4M) exceed its long term liabilities (NOK8.5M).


Debt to Equity History and Analysis

Debt Level: ELABS has more cash than its total debt.

Reducing Debt: Insufficient data to determine if ELABS's debt to equity ratio has reduced over the past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: ELABS has sufficient cash runway for more than 3 years based on its current free cash flow.

Forecast Cash Runway: ELABS has sufficient cash runway for more than 3 years if free cash flow continues to grow at historical rates of 23.1% each year


Discover healthy companies

Dividend

What is Elliptic Laboratories's current dividend yield, its reliability and sustainability?

Dividend Score

0/6

Dividend Score 0/6

  • Notable Dividend

  • High Dividend

  • Stable Dividend

  • Growing Dividend

  • Earnings Coverage

  • Cash Flow Coverage

Dividend Yield vs Market

Notable Dividend: Unable to evaluate ELABS's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate ELABS's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if ELABS's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if ELABS's dividend payments have been increasing.


Earnings Payout to Shareholders

Earnings Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Cash Payout to Shareholders

Cash Flow Coverage: Unable to calculate sustainability of dividends as ELABS has not reported any payouts.


Discover strong dividend paying companies

Management

How experienced are the management team and are they aligned to shareholders interests?

5.4yrs

Average management tenure


CEO

Laila Danielsen

9.17yrs

Tenure

Ms. Laila B. Danielsen serves as Chief Executive Officer and President of Elliptic Laboratories AS. Ms. Danielsen served as Vice President of sales at HotLink Corporation. Ms. Danielsen served as Vice Pres...


Leadership Team

Experienced Management: ELABS's management team is seasoned and experienced (5.4 years average tenure).


Board Members

Experienced Board: ELABS's board of directors are considered experienced (8.1 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 8.5%.


Top Shareholders

Company Information

Elliptic Laboratories ASA's employee growth, exchange listings and data sources


Key Information

  • Name: Elliptic Laboratories ASA
  • Ticker: ELABS
  • Exchange: OB
  • Founded: 2006
  • Industry: Application Software
  • Sector: Software
  • Implied Market Cap: kr2.123b
  • Shares outstanding: 104.05m
  • Website: https://www.ellipticlabs.com

Number of Employees


Location

  • Elliptic Laboratories ASA
  • Akersgata 32
  • Oslo
  • Oslo
  • 180
  • Norway

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2022/08/11 00:00
End of Day Share Price2022/08/11 00:00
Earnings2022/06/30
Annual Earnings2021/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.